Moreover, ZD6474-treated mice had significantly fewer small intestinal tumours, demonstrating the functional requirement of VEGFR, RET, and EGFR activity for the optimal growth of intestinal tumours with activated TGFβ/ALK5 signalling (Fig. 7c). This evidence concerns the gene TGFB1 and intestinal neoplasm.